Suppr超能文献

在胰腺癌相关骨骼肌减少症的临床前模型中,肌细胞脂质和 IGFBP-3 表达增加。

Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting.

机构信息

Department of Orthopaedics, University of Rochester Medical Center, Rochester, New York, USA.

Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York, USA.

出版信息

J Cachexia Sarcopenia Muscle. 2021 Jun;12(3):731-745. doi: 10.1002/jcsm.12699. Epub 2021 May 7.

Abstract

BACKGROUND

Skeletal muscle wasting (SMW) in cancer patients is associated with increased morbidity, mortality, treatment intolerance and discontinuation, and poor quality of life. This is particularly true for patients with pancreatic ductal adenocarcinoma (PDAC), as over 85% experience SMW, which is responsible for ~30% of patient deaths. While the established paradigm to explain SMW posits that muscle catabolism from systemic inflammation and nutritional deficiencies, the cause of death, and the cellular and molecular mechanisms responsible remain to be elucidated. To address this, we investigated the relationship between tumour burden and survival in the KCKO murine PDAC model.

METHODS

Female C57BL/6J mice 6-8 weeks of age underwent orthotopic injection with KCKO-luc tumour cells. Solid tumour was verified on Day 5, post-tumour inoculation. In vivo, longitudinal lean mass and tumour burden were assessed via dual-energy X-ray absorptiometry and IVIS imaging, respectively, and total body weight was assessed, weekly. Animals were sacrificed at a designated end point of 'failure to thrive'. After sacrifice, lower limb hind muscles were harvested for histology and RNA extraction.

RESULTS

We found a strong correlation between primary tumour size and survival (r  = 0.83, P < 0.0001). A significant decrease in lower limb lean mass was first detected at Day 38 post-implantation vs. no tumour controls (NTCs) (P < 0.0001). SMW was confirmed by histology, which demonstrated a 38%, 32.7%, and 39.9% decrease in fibre size of extensor digitorum longus, soleus, and tibialis anterior muscles, respectively, in PDAC mice vs. NTC (P < 0.002). Histology also revealed a 67.6% increase in haematopoietic cells within the muscle of PDAC mice when compared with NTC. Bulk RNAseq on muscles from PDAC mice vs. NTC revealed significant increases in c/ebpβ/Δ, il-1, il-6, and tnf gene expression. Pathway analyses to identify potential upstream factors revealed increased adipogenic gene expression, including a four-fold increase in igfbp-3. Histomorphometry of Oil Red-O staining for fat content in tibialis anterior muscles demonstrated a 95.5% increase in positively stained fibres from PDAC mice vs. NTC.

CONCLUSIONS

Together, these findings support a novel model of PDAC-associated SMW and mortality in which systemic inflammation leads to inflammatory cell infiltration into skeletal muscle with up-regulated myocellular lipids.

摘要

背景

癌症患者的骨骼肌减少(SMW)与发病率、死亡率、治疗不耐受和停药以及生活质量下降增加有关。对于胰腺导管腺癌(PDAC)患者来说尤其如此,超过 85%的患者会出现 SMW,这导致约 30%的患者死亡。虽然解释 SMW 的既定模式假设肌肉分解代谢来自全身炎症和营养缺乏,但导致死亡的原因以及负责的细胞和分子机制仍有待阐明。为了解决这个问题,我们研究了肿瘤负担与 KCKO 小鼠 PDAC 模型中生存之间的关系。

方法

6-8 周龄的雌性 C57BL/6J 小鼠接受 KCKO-luc 肿瘤细胞的原位注射。肿瘤接种后第 5 天证实实体瘤。在体内,通过双能 X 射线吸收仪和 IVIS 成像分别评估纵向瘦体重和肿瘤负担,每周评估一次总体体重。当动物出现“生长不良”的指定终点时,将其处死。死后,采集下肢后肢肌肉进行组织学和 RNA 提取。

结果

我们发现原发性肿瘤大小与生存之间存在很强的相关性(r=0.83,P<0.0001)。与无肿瘤对照(NTC)相比,植入后第 38 天首次检测到下肢瘦体重明显下降(P<0.0001)。组织学证实,PDAC 小鼠的伸趾长肌、比目鱼肌和胫骨前肌纤维大小分别减少 38%、32.7%和 39.9%(P<0.002)。组织学还显示,与 NTC 相比,PDAC 小鼠肌肉中的造血细胞增加了 67.6%。与 NTC 相比,PDAC 小鼠肌肉的批量 RNAseq 显示 c/ebpβ/Δ、il-1、il-6 和 tnf 基因表达显著增加。为确定潜在上游因素而进行的途径分析显示,脂肪生成基因表达增加,包括 igfbp-3 增加了四倍。胫骨前肌的油红 O 染色脂肪含量组织形态计量学显示,PDAC 小鼠阳性染色纤维增加了 95.5%(P<0.0001)。

结论

综上所述,这些发现支持一种新的 PDAC 相关 SMW 和死亡率模型,其中全身炎症导致炎症细胞浸润骨骼肌,并导致肌细胞内脂质上调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3ac/8200439/b62c33681169/JCSM-12-731-g008.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验